Johnson & Johnson Fined for Illegal Price Controls in Suit With China Distributor

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 1, 2013 -- Johnson & Johnson was ordered to pay a fine in China for monopolistic practices, in a suit stemming from a 2008 incident. Two of J&J’s subsidiaries were found guilty of enforcing price controls on a distributor. When the distributor won a public tender to sell J&J sutures – at a price below J&J’s stated minimum – J&J refused to supply product to the distributor. An appeals court awarded the distributor, Rainbow Medical, 530,000 RMB ($86,472). Rainbow had asked for a much larger 14 million RMB ($2.3 million). More details....

Stock Symbol: (NYSE: JNJ)

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC